Results 151 to 160 of about 9,259 (230)

Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion, EarlyView.
Elizabeth P. Crowe, Jennifer Andrews, Stella T. Chou, Claudia S. Cohn, Mischa L. Covington, Ruchika Goel, Aaron S. Hess, Tina S. Ipe, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Eric Salazar, Nabiha H. Saifee, Moritz Stolla, Nicole D. Zantek, Alyssa Ziman, Ryan A. Metcalf   +21 more
wiley   +1 more source

Pattern of Haemarthrosis in Haemophilia

Journal of Rawalpindi Medical College, 2013
Background: To study the pattern of haemarthrosis and its related complications in patients of Haemophilia A and B. Methods: Fifty one patients of Haemophilia A and B were evaluated on the basis of patient`s demographic data, history (family, medication,
Zahida Qasim
doaj  

Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX. [PDF]

J Clin Med
Park YS, Hwang TJ, Park SK, Choi EJ, Park JA, Baek HJ, Lyu CJ, Lee JH, Kim MK, Kim JY, Lee SA, Park B, Kim DH, Chung SB, Nam CM, Lee Y, Yoo KY.   +16 more
europepmc   +1 more source

High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. [PDF]

Haemophilia, 2020
Mancuso ME, Oldenburg J, Boggio L, Kenet G, Chan A, Altisent C, Seifert W, Santagostino E.   +7 more
europepmc   +1 more source

Orphan designation: Recombinant adeno-associated viral vector containing a bioengineered capsid and a codon-optimised expression cassette to drive the expression of the SQ form of a B-domain deleted human coagulation factor VIII, Treatment of haemophilia A [PDF]

, 2019

openalex   +1 more source

Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France. [PDF]

Ther Adv Hematol
Chambost H, Repessé Y, Genre-Volot F, Desprez D, Castet SM, Vanderbecken S, Zidi M, Gandossi C, Nüesch E, Palmborg H, Santagostino E, B-SURE Study Group.   +11 more
europepmc   +1 more source

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B. [PDF]

Glob Reg Health Technol Assess, 2020
Aiello A, Mancuso ME, Colombo A, Teruzzi C, Berto P.   +4 more
europepmc   +1 more source

Haemodialysis in a patient with haemophilia B [PDF]

Nephrology Dialysis Transplantation, 2007
Marian Klinger, J Kuzniar, Wacław Weyde, Mariusz Kusztal   +3 more
openaire   +2 more sources

Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross-Sectional Survey. [PDF]

Eur J Haematol
Clausen CML, Funding E, Tolver A, Jarden M.   +3 more
europepmc   +1 more source

Significant PK variability of plasma-derived FIX concentrates in chinese children with Haemophilia B: A fixed single-dose study of factor IX-CTBB. [PDF]

Glob Med Genet
Liu G, Ai D, Li G, Zhen Y, Wu X, Yao W, Wei Y, Li Z, Zhou Y, Wu R, Chen Z.   +10 more
europepmc   +1 more source